Cryopreservation of a small number of human sperm using enzymatically fabricated, hollow hyaluronan microcapsules handled by conventional ICSI procedures

J Assist Reprod Genet. 2016 Apr;33(4):501-11. doi: 10.1007/s10815-016-0656-x. Epub 2016 Jan 19.

Abstract

Purpose: We investigated whether enzymatically fabricated hyaluronan (HA) microcapsules were feasible for use in the cryopreservation of a small number of sperm.

Methods: HA microcapsules were fabricated using a system of water-immiscible fluid under laminar flow. Three sperm were injected into a hollow HA microcapsule using a micromanipulator. Capsules containing injected sperm were incubated in a freezing medium composed of sucrose as the cryoprotectant and then placed in a Cryotop® device and plunged into liquid nitrogen. After thawing, the capsule was degraded by hyaluronidase, and the recovery rate of sperm and their motility were investigated.

Results: The HA microcapsule measuring 200 μm in diameter and with a 30-μm thick membrane was handled using a conventional intracytoplasmic sperm injection (ICSI) system, and the procedure involved the injection of sperm into the capsule. The HA microcapsules containing sperm were cryopreserved in a Cryotop® device and decomposed by the addition of hyaluronidase. The recovery rate of sperm after cryopreservation and degradation of HA microcapsules was sufficient for use in clinical practice (90 %).

Conclusions: Hollow HA microcapsules can be used for the cryopreservation of a small number of sperm without producing adverse effects on sperm quality.

Keywords: Human sperm cryopreservation; Hyaluronan; ICSI; Microcapsule; Small number of sperm.

MeSH terms

  • Capsules / chemistry
  • Capsules / pharmacology
  • Cryopreservation*
  • Humans
  • Hyaluronic Acid / chemistry
  • Hyaluronic Acid / pharmacology
  • Male
  • Reproductive Techniques, Assisted*
  • Sperm Injections, Intracytoplasmic / methods*
  • Spermatozoa / drug effects
  • Spermatozoa / physiology*

Substances

  • Capsules
  • Hyaluronic Acid